Crossmark

Delivering base editors to the lungs

Crossref DOI link: https://doi.org/10.1038/s41563-026-02602-w

Published Online: 2026-05-22

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Cao, Dinglingge https://orcid.org/0009-0007-3776-7474
Dong, Yizhou https://orcid.org/0000-0001-5786-0659
License Information

Text and Data Mining valid from 2026-05-22

Version of Record valid from 2026-05-22
More Information

Article History

First Online: 22 May 2026

Competing interests

: Y.D. is a co-founder and holds equity in Immunanoengineering Therapeutics. D.C. declares no competing interests.